Peter Sordillo
Chief Tech/Sci/R&D Officer at SignPath Pharma, Inc.
Peter Sordillo active positions
| Companies | Position | Start | End |
|---|---|---|---|
SignPath Pharma, Inc.
 SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Chief Tech/Sci/R&D Officer | 2017-05-31 | - |
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - | - |
Career history of Peter Sordillo
Former positions of Peter Sordillo
| Companies | Position | Start | End |
|---|---|---|---|
| New York University School of Medicine | Corporate Officer/Principal | - | - |
| Weill Cornell Medical College | Corporate Officer/Principal | - | - |
Training of Peter Sordillo
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| New York University | Graduate Degree |
| New York Medical College | Graduate Degree |
| Columbia College (New York) | Undergraduate Degree |
Statistics
International
| United States | 9 |
Operational
| Graduate Degree | 3 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 8 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |
- Stock Market
- Insiders
- Peter Sordillo
- Experience
